“Secukinumab Reduces Endothelial Dysfunction in Subjects With Moderate-to-Severe Plaque Psoriasis Over 52 Weeks: Results of the Exploratory CARIMA Study”. SKIN The Journal of Cutaneous Medicine 2, no. S1 (February 23, 2018): S20. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/290.